|
As the delta variant surges, some experts worry we may be entering the most dangerous moment in the pandemic for children |
mike kraft |
Group Post |
08/13/21 |
|
As the omicron variant threatens to wipe out monoclonal antibodies, the U.S. is saving up one that will still work |
mike kraft |
Group Post |
12/17/21 |
|
As Trump Praises Plasma, Researchers Struggle to Finish Critical Studies |
mike kraft |
Group Post |
08/04/20 |
|
As UK prepares to roll out COVID-19 vaccines, scepticism remains |
mike kraft |
Group Post |
12/07/20 |
|
As Virus Cases Surge in Europe, Hospitalizations Lag. But for How Long? |
mike kraft |
Group Post |
09/25/20 |
|
As virus flares globally, governments use new strategies to target hot spots |
mike kraft |
Group Post |
10/19/20 |
|
As Virus Grows Stealthier, Vaccine Makers Reconsider Battle Plans |
mike kraft |
Group Post |
01/26/21 |
|
As virus spikes, Europe runs low on ICU beds, hospital staff |
mike kraft |
Group Post |
11/10/20 |
|
As Virus Spreads, C.D.C. Draws Up an Urgent Battle Plan |
mike kraft |
Group Post |
12/05/20 |
|
As winter COVID surge begins, 74 percent of Americans say their lives have returned to 'normal' --Poll |
mike kraft |
Group Post |
11/23/21 |
|
ASEAN considering supporting Japan recovery with policy changes |
JRees |
Story |
04/10/11 |
|
Asia Roundup of COVID-19 developments -_AP |
mike kraft |
Group Post |
11/29/20 |
|
Asia are opening up for travel -- except for China |
mike kraft |
Group Post |
10/13/22 |
|
Asia Developments, South Korea first shots, China approves 2 more vaccines |
mike kraft |
Group Post |
02/26/21 |
|
Asia Has Beaten Back Each Wave of COVID-19. But This Surge Could Be Different |
mike kraft |
Group Post |
12/05/20 |
|
Asia keeps omicron at bay for now, but worries about a surge that already hit Australia |
mike kraft |
Group Post |
12/29/21 |
|
Asia Overview: India's virus cases jump on New Delhi resurgence |
mike kraft |
Group Post |
11/05/20 |
|
Asia Today: Restrictions in S. Korea, India cases hit 2.5M |
mike kraft |
Group Post |
08/15/20 |
|
Asia Today: South Korea OKs single test for COVID-19 and flu |
mike kraft |
Group Post |
11/04/20 |
|
Asia's COVID deaths surpass 1 million |
mike kraft |
Group Post |
03/11/22 |
|
Asia-Pacific region overview |
mike kraft |
Group Post |
10/17/20 |
|
Asia/Pacific: Australia to spend on vaccines for wider region |
mike kraft |
Group Post |
10/31/20 |
|
Asia: 5.9 million COVID infections overwhelm hospitals --Red Cross |
mike kraft |
Group Post |
05/12/21 |
|
Asia: COVID cases surpass 100 million |
mike kraft |
Group Post |
03/30/22 |
|
Asian cities virus-proof public transit with smart shelters, thermal scanners |
mike kraft |
Group Post |
08/17/20 |
|
Asian-Pacific countries, lagging in jabs, still rely on supression tactics |
mike kraft |
Group Post |
06/22/21 |
|
Aspirin to be investigated as a possible treatment for COVID-19 in the RECOVERY trial |
mike kraft |
Group Post |
11/06/20 |
|
Assessment of pandemic's effect on mental health in Europe |
mike kraft |
Group Post |
06/20/23 |
|
Assessment of the impact of war on the enviornment and health and recover in Ukraine l |
mike kraft |
Group Post |
09/19/22 |
|
Asthma patients report worse asthma control after COVID-19 |
mike kraft |
Group Post |
02/16/23 |
|
Astra antibody cocktail did not prevent COVID-19 symptoms in large trial |
mike kraft |
Group Post |
06/15/21 |
|
AstraZeneca admits its Covid vaccine can cause rare side effect -- British court documents |
mike kraft |
Group Post |
04/29/24 |
|
AstraZeneca antibody cocktail study shows success treating COVID-19 |
mike kraft |
Group Post |
10/11/21 |
|
AstraZeneca asks FDA for emergency authorization for new COVID treatment |
Naomisfreeman |
Group Post |
10/06/21 |
|
AstraZeneca commits to releasing more complete vaccine data after concerns from NIH |
mike kraft |
Group Post |
03/23/21 |
|
AstraZeneca court case: EU says company did ‘not even try’ to meet Covid vaccine contract |
mike kraft |
Group Post |
05/26/21 |
|
AstraZeneca COVID drug neutralises Omicron sub-variants in lab study |
mike kraft |
Group Post |
03/21/22 |
|
AstraZeneca COVID therapy getts backing from EU regulator |
mike kraft |
Group Post |
09/16/22 |
|
AstraZeneca COVID-19 vaccine shows 74% efficacy in large U.S. trial |
mike kraft |
Group Post |
09/29/21 |
|
AstraZeneca Covid-19 vaccine study put on hold due to suspected adverse reaction in participant in the U.K. |
mike kraft |
Group Post |
09/08/20 |
|
AstraZeneca COVID-19 vaccine trial in U.S. on hold until at least midweek - Reuters sources |
mike kraft |
Group Post |
09/15/20 |
|
AstraZeneca developments: Oxford suspends trial with children, European official says casual link with rare blot cots |
mike kraft |
Group Post |
04/06/21 |
|
AstraZeneca resumes trials of COVID vaccine halted by patient illness |
mike kraft |
Group Post |
09/12/20 |
|
AstraZeneca safety controversy, shipping issues |
mike kraft |
Group Post |
03/12/21 |
|
AstraZeneca says COVID vaccine as effective as mRNA shots in review |
mike kraft |
Group Post |
07/13/22 |
|
AstraZeneca says COVID-19 'vaccine for the world' can be 90% effective |
mike kraft |
Group Post |
11/23/20 |
|
AstraZeneca says early trial data indicates third dose helps against Omicron |
mike kraft |
Group Post |
01/13/22 |
|
AstraZeneca says EU loses legal bid for more vaccine supplies by end-June |
mike kraft |
Group Post |
06/18/21 |
|
AstraZeneca says it is on track to meet Southeast Asia vaccine orders |
mike kraft |
Group Post |
06/28/21 |
|
AstraZeneca says its vaccine is effective against COVID-19 variants identified in India |
mike kraft |
Group Post |
06/22/21 |
Recent Comments